Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.

Kuttler B, Mathieu C, Bulfone-Paus S, Bouillon R, Diamantstein T, Hahn HJ.

Transplant Proc. 1998 Dec;30(8):4140-2. No abstract available.

PMID:
9865327
2.

Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15).

Krause H, Jandrig B, Wernicke C, Bulfone-Paus S, Pohl T, Diamantstein T.

Cytokine. 1996 Sep;8(9):667-74.

PMID:
8932977
3.

Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.

Kuttler B, Kauert C, Wanka H, Diamantstein T, Hahn HJ.

J Autoimmun. 1996 Jun;9(3):321-9.

PMID:
8816967
4.

Effects of depletion of cells bearing the interleukin-2 receptor on immunoglobulin production and allergic airway responses in the rat.

Renzi PM, Yang JP, Diamantstein T, Martin JG.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1214-21.

PMID:
8616544
5.

Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.

Kunzendorf U, Pohl T, Bulfone-Paus S, Krause H, Notter M, Onu A, Walz G, Diamantstein T.

J Clin Invest. 1996 Mar 1;97(5):1204-10.

6.

The rat interleukin 4 receptor: coevolution of ligand and receptor.

Richter G, Hein G, Blankenstein T, Diamantstein T.

Cytokine. 1995 Apr;7(3):237-41.

PMID:
7640343
7.

Production of cytokines by human melanoma cells and melanocytes.

Krüger-Krasagakes S, Krasagakis K, Garbe C, Diamantstein T.

Recent Results Cancer Res. 1995;139:155-68.

PMID:
7597287
8.

Expression of interleukin 10 in human melanoma.

Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hüls C, Blankenstein T, Diamantstein T.

Br J Cancer. 1994 Dec;70(6):1182-5.

9.

Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.

Volk HD, Müller S, Yarkoni S, Diamantstein T, Lorberboum-Galski H.

J Immunol. 1994 Sep 15;153(6):2497-505.

PMID:
8077661
11.

Tyrosine phosphorylation of Shc is induced by IL-3, IL-5 and GM-CSF.

Dorsch M, Hock H, Diamantstein T.

Biochem Biophys Res Commun. 1994 Apr 15;200(1):562-8.

PMID:
7513165
12.

Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy.

Hock H, Dorsch M, Richter G, Kunzendorf U, Krüger-Krasagakes S, Blankenstein T, Qin Z, Diamantstein T.

Nat Immun. 1994 Mar-Jun;13(2-3):85-92. Review.

PMID:
8173239
13.

A sialyl-Le(x)-negative melanoma cell line binds to E-selectin but not to P-selectin.

Kunzendorf U, Krüger-Krasagakes S, Notter M, Hock H, Walz G, Diamantstein T.

Cancer Res. 1994 Feb 15;54(4):1109-12.

PMID:
7508820
14.

T cells bind to the endothelial adhesion molecule GMP-140 (P-selectin).

Kunzendorf U, Notter M, Hock H, Distler A, Diamantstein T, Walz G.

Transplantation. 1993 Nov;56(5):1213-7.

PMID:
7504345
15.

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.

Richter G, Krüger-Krasagakes S, Hein G, Hüls C, Schmitt E, Diamantstein T, Blankenstein T.

Cancer Res. 1993 Sep 15;53(18):4134-7.

16.

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.

Qin Z, Krüger-Krasagakes S, Kunzendorf U, Hock H, Diamantstein T, Blankenstein T.

J Exp Med. 1993 Jul 1;178(1):355-60.

17.

An examination of the immune system of the duck (Anas platyrhynchos) for factors resembling some defined mammalian cytokines.

Higgins DA, Cromie RL, Srivastava G, Herzbeck H, Schlüter C, Gerdes J, Diamantstein T, Flad HD.

Dev Comp Immunol. 1993 Jul-Aug;17(4):341-55.

PMID:
7690719
18.

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.

Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T.

Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2774-8.

19.

Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth.

Krüger-Krasagakes S, Li W, Richter G, Diamantstein T, Blankenstein T.

Eur J Immunol. 1993 Apr;23(4):992-5.

PMID:
8458388
20.

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant.

Hock H, Dorsch M, Kunzendorf U, Uberla K, Qin Z, Diamantstein T, Blankenstein T.

Cancer Res. 1993 Feb 15;53(4):714-6.

21.

Interleukin-2 receptor-targeted immune therapy.

Diamantstein T, Hahn HJ.

Immunol Ser. 1993;59:295-318. Review. No abstract available.

PMID:
8461395
22.

Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression.

Dorsch M, Hock H, Kunzendorf U, Diamantstein T, Blankenstein T.

Eur J Immunol. 1993 Jan;23(1):186-90.

PMID:
8419170
23.
24.

Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells.

Bohn J, Josimovic-Alasevic O, Settmacher U, Kiessig ST, Lukowsky A, Volk HD, Diamantstein T, Von Baehr R, Jahn S.

Res Immunol. 1992 Nov-Dec;143(9):879-91.

PMID:
1289988
25.

Extended survival of MHC-identical allogeneic islet grafts in diabetic BB rats--the effect of an interleukin 2 receptor-targeted immunotherapy.

Hahn HJ, Kuttler B, Klöting I, Dunger A, Besch W, Diamantstein T.

Transplantation. 1992 Sep;54(3):555-8. No abstract available.

PMID:
1412738
26.

Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression.

Rothe H, Schuller I, Richter G, Jongeneel CV, Kiesel U, Diamantstein T, Blankenstein T, Kolb H.

Immunology. 1992 Sep;77(1):1-6.

27.

Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma.

Platzer C, Richter G, Uberla K, Hock H, Diamantstein T, Blankenstein T.

Eur J Immunol. 1992 Jul;22(7):1729-33.

PMID:
1623921
28.

Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction.

Platzer C, Richter G, Uberla K, Müller W, Blöcker H, Diamantstein T, Blankenstein T.

Eur J Immunol. 1992 May;22(5):1179-84.

PMID:
1533590
29.

Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.

Feist W, Ulmer AJ, Wang MH, Musehold J, Schlüter C, Gerdes J, Herzbeck H, Brade H, Kusumoto S, Diamantstein T, et al.

FEMS Microbiol Immunol. 1992 Jan;4(2):73-89.

PMID:
1547025
30.

[Immunorestitutive action of hydrolysates and ultrafiltrates of bovine spleen].

Volk HD, Eckert R, Diamantstein T, Schmitz H.

Arzneimittelforschung. 1991 Dec;41(12):1281-5. German.

PMID:
1815529
31.

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

Hock H, Dorsch M, Diamantstein T, Blankenstein T.

J Exp Med. 1991 Dec 1;174(6):1291-8.

33.

Generation of competitor DNA fragments for quantitative PCR.

Uberla K, Platzer C, Diamantstein T, Blankenstein T.

PCR Methods Appl. 1991 Nov;1(2):136-9.

35.

Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease.

Jücker M, Abts H, Li W, Schindler R, Merz H, Günther A, von Kalle C, Schaadt M, Diamantstein T, Feller AC, et al.

Blood. 1991 Jun 1;77(11):2413-8.

36.

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

Blankenstein T, Qin ZH, Uberla K, Müller W, Rosen H, Volk HD, Diamantstein T.

J Exp Med. 1991 May 1;173(5):1047-52.

37.
38.

Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.

Hahn HJ, Kuttler B, Dunger A, Lucke S, Volk HD, Diamantstein T.

Transplant Proc. 1991 Feb;23(1 Pt 1):741-2. No abstract available.

PMID:
1990673
39.

Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.

Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.

Transplant Proc. 1991 Feb;23(1 Pt 1):281-2. No abstract available.

PMID:
1990532
40.

Combined anti-interleukin-2 receptor and low-dose cyclosporine therapy in experimental autoimmune uveoretinitis.

Higuchi M, Diamantstein T, Osawa H, Caspi RR.

J Autoimmun. 1991 Feb;4(1):113-24.

PMID:
1827711
41.

The interleukin-6 gene locus seems to be a preferred target site for retrotransposon integration.

Qin ZH, Schuller I, Richter G, Diamantstein T, Blankenstein T.

Immunogenetics. 1991;33(4):260-6.

PMID:
1851139
42.

The role of dipeptidylpeptidase IV positive T cells in wound healing and angiogenesis.

Kohl A, Volk HD, Buntrock P, Kohl G, Diamantstein T, von Baehr R.

Agents Actions. 1991 Jan;32(1-2):125-7. No abstract available.

PMID:
1711765
43.

The rat interleukin-5 gene: characterization and expression by retroviral gene transfer and polymerase chain reaction.

Uberla K, Li WQ, Qin ZH, Richter G, Raabe T, Diamantstein T, Blankenstein T.

Cytokine. 1991 Jan;3(1):72-81.

PMID:
1653053
44.
45.

Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity.

Blankenstein T, Li WQ, Uberla K, Qin ZH, Tominaga A, Takatsu K, Yamaguchi N, Diamantstein T.

Eur J Immunol. 1990 Dec;20(12):2699-705.

PMID:
2269330
46.

Tumor cell targeted cytokine (TNF-alpha) gene therapy for cancer.

Blankenstein T, Qin Z, Uberla K, Volk HD, Diamantstein T.

Immunol Today. 1990 Dec;11(12):431. No abstract available.

PMID:
2073314
47.

The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.

Ueda H, Hancock WW, Cheung YC, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.

Transplantation. 1990 Oct;50(4):545-50.

PMID:
2219270
48.

Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.

Tanaka K, Tilney NL, Stunkel KG, Hancock WW, Diamantstein T, Kupiec-Weglinski JW.

Proc Natl Acad Sci U S A. 1990 Oct;87(19):7375-9.

49.

Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

Kretschmer C, Jones DB, Morrison K, Schlüter C, Feist W, Ulmer AJ, Arnoldi J, Matthes J, Diamantstein T, Flad HD, et al.

Am J Pathol. 1990 Aug;137(2):341-51.

50.

Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms.

Pizzolo G, Stein H, Josimovic-Alasevic O, Vinante F, Zanotti R, Chilosi M, Feller AC, Diamantstein T.

Br J Haematol. 1990 Aug;75(4):485-8.

PMID:
2119791

Supplemental Content

Loading ...
Support Center